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Abstract 
Since nasal NK/T cell lymphoma and NK/T
cell  lymphoma  nasal  type  are  rare  diseases,
gastric involvement has seldom been seen. We
report a unique case of a patient with a pri-
mary  NK/T  cell  lymphoma  nasal  type  of  the
stomach  with  skin  involvement.  The  patient
had no history of malignant diseases and was
diagnosed  with  hematemesis  and  intense
bleeding from his gastric primary site. Shortly
after  this  event,  exanthemic  skin  lesions
appeared with concordant histology to the pri-
mary site. Despite chemotherapy, the patient
died  one  month  after  the  first  symptomatic
appearance of disease.
Introduction
According to the WHO classification of lym-
phoma, the NK cell type can be classified into
3 subgroups: NK/T cell lymphoma nasal/nasal
type, NK cell leukemia and chronic lymphopro-
liferative disorders of NK cells.
1,2 Among non-
Hodgkin’s  lymphomas,  NK/T  cell  lymphoma
nasal type is a very rare subtype, predominant-
ly found in East Asia. There it makes up 2-10%
of NHL (non-Hodgkin’s lymphoma).
3 It is pri-
marily  located  in  the  nasal/nasopharyngeal
region (75%), the skin (4%), the gastrointesti-
nal  tract  (6%),  the  bone  marrow  and  the
spleen.
4 NK/T cell lymphoma nasal type is diag-
nosed  by  immunophenotyping.  The  typical
phenotype  has  been  described  as  CD2
+,
CD3/Leu4
–, CD3ε
+, CD3
–, CD56
+, TCR germline
and generally EBV
+.
5 Based on histological cri-
teria,  angiocentric  and/or  angiodestructive
behavior with mixed in cell morphology (small,
medium and large cells) is often found.
6 This
type is known to be highly aggressive and asso-
ciated with a very poor prognosis in dissemi-
nated disease.
7 Primary gastric lymphomas are
rare,  especially  of  the  NK/T  cell  nasal  type.
8
According to literature only 2 cases of primary
gastric  NK/T  cell  lymphoma  nasal  type  have
been reported.
9,10 These patients did not show
involvement  of  other  sites  except  stomach.
They died shortly after diagnosis. 
Case Report
A 69-year old Caucasian man was first hos-
pitalized with hematemesis and melena. The
endoscopic  examination  revealed  a  bleeding
duodenal ulcer, Forrest 1a and a second ulcer
in  the  antrum  of  the  stomach  (Figure  1).
Biopsies were taken from the gastric ulcer. The
pathological  examination  revealed  a  high-
grade lymphoma of the stomach. Roughly, the
histo-morphology showed an angiocentric and
angiodestructive growth pattern with a mixed
cell population accompanied by a heavy admix-
ture  of  inflammatory  cells.  Immunohisto-
chemistry revealed positivity for CD2, CD56,
and a weak expression of CD20, as well as a
negative stain for CD4, CD5, CD7, CD8, CD30,
CD33, CD34, CD79a, CD103, CD117 and CD138
(Figure  2).  A  CD3ε,  stain  on  a  fresh  tissue
sample was also positive. The neoplastic cells
showed strong granular staining for the cyto-
toxic  molecules  granzyme  B,  perforin  and
TIA1. The immunostaining with a monoclonal
antibody for the anaplastic lymphoma kinase
(ALK) was negative. The molecular analysis of
the TCR g-chain-locus showed a germline con-
figuration. By analyzing the samples for IgH
gene rearrangement by PCR analysis, no clon-
al rearrangement could be found.
11 Although
EBER  (EBV  encoded  small  nuclear  RNAs)
expression was negative which is an unususal
finding for nasal NK-T-cell lymphoma; we per-
formed an LMP-1 stain, revealing strong cyto-
plasmatic and surface membrane expression
in almost all lymphoma cells. Therefore, pres-
ence  of  an  EBV-related  lymphoma  could  be
concluded. A NK/T cell lymphoma, nasal type
with partial aberrant expression of CD20 was
diagnosed. The patient underwent the usual
staging examinations with clinical exam, com-
putertomographic assessment of the chest, the
abdomen and the pelvis, a bone marrow biopsy
and a positron emission tomography. None of
these assessments uncovered another involved
site. In particular, the nasal and nasopharyn-
geal regions as well as the bone marrow, were
free  of  disease.  No  lymphadenopathy  was
found. The patient had no history of celiac dis-
ease and serological analysis was negative for
specific  antibodies.  The  LDH  was  865U/L  at
time of diagnosis. The patient’s medical histo-
ry  was  insignificant  apart  from  newly  diag-
nosed diabetes and the loss of 10% body weight
in the previous four months rated as B-symp-
toms. The patient met the Dawson criteria for
primary intestinal lymphoma.
12
In  addition,  shortly  after  the  symptomatic
appearance of his disease, the patient devel-
oped  exanthemic  non-pruriginous  skin
lesions.  A  biopsy  was  performed  and  the
immunohistochemical assessment showed the
same  expression  profile  as  described  above
(Figure 3). Dermal spread of the NK/T cell lym-
phoma  nasal  type  was  concluded.  It  can  be
deducted that the patient had a stage IVB dis-
ease before the start of the therapy.
Chemotherapy  using  the  CHOP-protocol
(cyclophosphamid, hydroxydaunorubicin, onco-
vin, prednison) was applied and well tolerated
by the patient. About a week later, the patient
developed  grade  IV  hematoxicity,  becoming
aplastic and septic. Supportive care was pro-
vided with antibiotic escalation and parenteral
support. Meanwhile skin infiltration increased
with several new lesions. Despite all efforts,
the patient died of septic complications, most-
ly due to a severe pneumonia. The patient’s
relatives declined autopsy.
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Discussion
The presence of this rare tumor lead us to
various  differential  diagnoses.  First,  an
anaplastic large cell lymphoma (ALCL) was dis-
cussed. According to the latest WHO classifica-
tion, these lymphomas are CD30 positive, and
are in 80% of all cases ALK positive. As the
present  lymphoma  completely  lacked  expres-
sion of these markers, an ALCL could be exclud-
ed.  Enteropathy-associated  T-cell  lymphoma
(EATL) was then taken into consideration. The
WHO
1 defines the polymorphic form (type I) of
EATL  as  CD3
+,  CD5
–,  CD7
–,  CD8
+/-,  CD4
–,
CD103
+, TCRb
+/-and cytotoxic proteins positive.
The monomorphic form (type II) is defined as
CD3
+, CD4
–, CD8
+, CD56
+ and TCRb
+. The lym-
phoma cells were completely negative for these
markers  except  CD56  and  the  cytotoxic  pro-
teins. These markers are insufficient for the
diagnosis of EATL.
1 A primary cutaneous g-d T-
cell  lymphoma  was  excluded  because  of  the
negativity for CD3 and the TCR germline con-
figuration, required for diagnosis by the WHO
classification.
1 Finally, a peripheral T-cell lym-
phoma not otherwise specified was considered
due to the typical involvement of skin and stom-
ach.
1 CD4
+ and clonal TCR gene rearrangement
is most frequently seen, in contrast to the pres-
ent case, albeit a false negative TCR rearrange-
ment and a negative stain for CD4 have been
described before.
1 In addition, a peripheral T-
cell  lymphoma  not  otherwise  specified  could
only be diagnosed if other lymphoma types are
ruled out. As the morphology didn’t match the
typical morphology of such a peripheral T-cell
lymphoma  we  didn’t  favor  this  diagnosis.
Because of the CD20 positivity, a B-cell lym-
phoma was considered, but given the negativi-
ty  for  CD79a  and  a  lack  of  clonal  IgH  gene
rearrangement associated with the above men-
tioned immunohistochemical profile, a B-NHL
seemed very unlikely. An aberrant expression
of CD20 was concluded.
We  compared  the  findings  in  the  present
patient with a recent analysis on the largest
series of NK/T-cell lymphoma.
13 As was seen in
this collective, CD2, CD3ε, TIA-1, granzyme B
and  CD56  stainings  were  positive.  Although
CD30 was negative in our extranasal case, it
was negative in 37% of cases in this series and
it is not a prerequisite according to WHO clas-
sification. The germline configuration of TCR
fits into the findings of this series, as most
extranasal cases were found negative for TCR
rearrangement.  The  EBER  positivity  was  an
obligatory inclusion criteria in this study. The
strong LMP-1 expression of the present case,
which points towards an EBV-associated lym-
phoma, can easily weigh out the EBER negativ-
ity for EBV diagnosis.
Finally the immunophenotype of this partic-
ular tumor concurred only with an extranodal
NK/T-cell lymphoma nasal type. The EBER-neg-
ativity could be explained by a low quality of
preservation  of  the  paraffin  wax-embedded
blocks
14or by a lack of expression of EBER-1, as
has been reported in other tumors.
14,15 Our find-
ings argue in favor of the combination of EBER
and  LMP-1  analysis  to  assess  EBV  status  of
lymphomas, as is recommended in Hodgkin’s
lymphomas.
16
Several authors have advocated the estab-
lishment of a prognostic model for NK/T cell
lymphoma nasal type that is more reliable than
IPI
1,7,17,18 (International  Prognostic  Index).
Case Report
Figure 2. Immunostain-ing with monoclonal antibody directed against CD56 (A) and
CD2 (B). Nearly all the stomach infiltrating cells were positive.
Figure 3. Immunostain-ing with monoclonal antibody directed against CD56 (A) and
CD2 (B). About 80% of the skin infiltrating cells were positive.
Figure 1. Endoscopic appearances of primary gastric NK
–/T−cell lymphoma: ulcerative
type.[Rare Tumors 2009; 1:e58] [page 175]
Factors significantly associated with a worse
prognosis are male gender, the presence of B-
symptoms,  high  LDH,  advanced  stage  and
CD30 negativity. In our case, the patient pos-
sessed all negative prognostic factors and died
shortly after diagnosis.
Past  experiences  with  the  CHOP-regi-
menindicated that it might not be an adequate
therapeutic approach for advanced stage dis-
ease.
19 Some  authors  have  suggested  high-
dose chemotherapy associated with autologous
or allogeneic transplantation for patients with
NK/T cell lymphoma nasal type and poor prog-
nosis.
20,21 In this case, the general condition of
the patient at the start of the therapy did not
allow such an aggressive approach. Therefore,
the  standard  CHOP  therapy  was  chosen  in
order to improve the overall condition of the
patient.
22
To our knowledge, this patient is a unique
case of a primary NK/T cell lymphoma of the
stomach  with  skin  involvement.  To  date,  no
conclusive  theory  has  been  described  to
explain  why  this  type  of  lymphoma  remains
confined to these unusual locations.
22 We hope
that our experience might help in the under-
standing of this very rare disease.
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